Examine This Report on Antidepressant agent 5
The first stop issue was the security and tolerability of sifalimumab. Treatment-emergent adverse functions (AEs) and serious AEs (SAEs) and their severity, consequence, and any partnership to your study medication were being recorded via the investigator all through the analyze. AEs were being deemed more likely to be relevant to analyze medicatio